ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671415 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671415; 2) Community: the network communities that were significantly associated with the response to NSC 671415; 3) Molecule: the relationships between components within communities and NSC 671415; 4) MDR: the compounds that were significantly associated with the NSC 671415.

NSC Compound Enrichment Correlation
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.00896740831404543 0.04360469
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.00896740831404549 0.17019863
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.00896740831404549 0.16433499
NSC 618487 STAUROSPORINE 0.00896740831404562 -0.31404567
NSC 210717 Ellipticine, 9-hydroxy-, hydrochloride 0.00910228844192553 -0.055276799
NSC 669889 Null 0.00910228844192553 0.1833395
NSC 683666 Null 0.0091022884419256 0.19150173
NSC 728188 7-Chloro -4- ( 4,6-dimethyl thio- pyrazolo [3,4-d] pyrimidine-1-yl)-Quinoline 0.0091022884419256 0.021201391
NSC 729211 cis-3-O-p-hydroxycinnamoyl ursolic acid 0.0091022884419256 0.045978694
NSC 753393 3-[2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0091022884419256 0.22855414
Total:50  Current:10    [First] [Prev] [Next] [Last]